166 related articles for article (PubMed ID: 22782602)
1. Immunophenotyping and extracellular matrix remodeling in pulmonary and extrapulmonary sarcoidosis.
Silva PH; Parra ER; Zocolaro WS; Narde I; Rodrigues F; Kairalla RA; Carvalho CR; Capelozzi VL
J Bras Pneumol; 2012; 38(3):321-30. PubMed ID: 22782602
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping and remodeling process in small airways of idiopathic interstitial pneumonias: functional and prognostic significance.
Parra ER; Noleto GS; Tinoco LJ; Capelozzi VL
Clin Respir J; 2008 Oct; 2(4):227-38. PubMed ID: 20298339
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotyping of epithelioid-cell granulomas in sarcoidosis].
Guntupova LD; Borisov SE; Typitsyn NN; Solov'eva IP; Ots ON; Latyshev AN; Semenov GI
Probl Tuberk Bolezn Legk; 2006; (4):50-4. PubMed ID: 16813062
[TBL] [Abstract][Full Text] [Related]
4. Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers.
Negri EM; Hoelz C; Barbas CS; Montes GS; Saldiva PH; Capelozzi VL
Pathol Res Pract; 2002; 198(5):355-61. PubMed ID: 12092772
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process.
Felício CH; Parra ER; Capelozzi VL
Lung; 2007; 185(1):39-46. PubMed ID: 17294340
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
da Costa Souza P; Dondo PS; Souza G; Lopes D; Moscardi M; de Miranda Martinho V; de Mattos Lourenço RD; Prieto T; Balancin ML; Assato AK; Teodoro WR; Rodrigues S; Lima M; Castellano MV; Coletta E; Parra ER; Capelozzi VL
Hum Pathol; 2018 May; 75():104-115. PubMed ID: 29410258
[TBL] [Abstract][Full Text] [Related]
7. Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity.
Shamaei M; Mortaz E; Pourabdollah M; Garssen J; Tabarsi P; Velayati A; Adcock IM
Hum Immunol; 2018 Jan; 79(1):63-69. PubMed ID: 29107084
[TBL] [Abstract][Full Text] [Related]
8. Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis.
Samokhin AO; Gauthier JY; Percival MD; Brömme D
Respir Res; 2011 Jan; 12(1):13. PubMed ID: 21251246
[TBL] [Abstract][Full Text] [Related]
9. The pathology of pulmonary sarcoidosis: update.
Ma Y; Gal A; Koss MN
Semin Diagn Pathol; 2007 Aug; 24(3):150-61. PubMed ID: 17882899
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China.
Li CW; Tao RJ; Zou DF; Li MH; Xu X; Cao WJ
BMJ Open; 2018 Feb; 8(2):e018865. PubMed ID: 29453299
[TBL] [Abstract][Full Text] [Related]
11. Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation.
Koura T; Gon Y; Hashimoto S; Azuma A; Kudoh S; Fukuda Y; Sugawara I; Yodoi J; Horie T
Thorax; 2000 Sep; 55(9):755-61. PubMed ID: 10950894
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
13. Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis.
Kempf W; Zollinger T; Sachs M; Ullmer E; Cathomas G; Dirnhofer S; Mertz KD
Hum Pathol; 2014 Nov; 45(11):2202-10. PubMed ID: 25200795
[TBL] [Abstract][Full Text] [Related]
14. Current Sarcoidosis Models and the Importance of Focusing on the Granuloma.
Locke LW; Schlesinger LS; Crouser ED
Front Immunol; 2020; 11():1719. PubMed ID: 32849608
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis.
Limper AH; Colby TV; Sanders MS; Asakura S; Roche PC; DeRemee RA
Am J Respir Crit Care Med; 1994 Jan; 149(1):197-204. PubMed ID: 8111583
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of structural and cellular components in pulmonary sarcoidosis granuloma].
Voss B; Wiethege T; Schweikardt B; Müller KM
Pneumologie; 1996 Apr; 50(4):303-10. PubMed ID: 8685205
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognostic significance of splenic involvement in sarcoidosis.
Tetikkurt C; Yanardag H; Pehlivan M; Bilir M
Monaldi Arch Chest Dis; 2017 Dec; 87(3):893. PubMed ID: 29424195
[TBL] [Abstract][Full Text] [Related]
19. Pregranulomatous phase of sarcoidosis: immunohistochemical diagnosis.
Jaskiewicz K; Rzepko R; Dubaniewicz A; Jassem E; Raczynska K
Acta Histochem; 2006; 107(6):473-7. PubMed ID: 16256177
[TBL] [Abstract][Full Text] [Related]
20. Sarcoidosis--immunopathogenetic concepts.
Zissel G; Prasse A; Müller-Quernheim J
Semin Respir Crit Care Med; 2007 Feb; 28(1):3-14. PubMed ID: 17330188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
